Evaluation of Insulin-like Growth Factor Receptor 1 Inhibition as a Treatment for Prostate Cancer: Preclinical Efficacy and Resistance

K. J. Pienta, S. Korenchuk, S. Whitney, L. McLean, R. Vessella, Y. G. Lee, J. E. Lehr, D. L. Lin, VCaP, a cell-based model system of human prostate cancer. in Vivo. ,vol. 15, pp. 163- 168 ,(2001)

Qingyi Wei, Zhongxing Liao, Ming Yin, Xiaoxiang Guan, Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review. American Journal of Translational Research. ,vol. 1, pp. 101- 114 ,(2009)

Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121

Richard Poulsom, Valentine M. Macaulay, Gareth D. H. Turner, David R. Davies, Simon F. Brewster, Giles O. Hellawell, Expression of the Type 1 Insulin-like Growth Factor Receptor Is Up-Regulated in Primary Prostate Cancer and Commonly Persists in Metastatic Disease Cancer Research. ,vol. 62, pp. 2942- 2950 ,(2002)

Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Daniel S Pereira, Rajiv Bassi, Rashed Abdullah, Andrea T Hooper, Henry Koo, Xenia Jimenez, Danielle Johnson, Robin Apblett, Paul Kussie, Peter Bohlen, Larry Witte, Daniel J Hicklin, Dale L Ludwig, None, A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo Cancer Research. ,vol. 63, pp. 8912- 8921 ,(2003)

Thomas G. Pretlow, Clifford G. Tepper, David L. Boucher, Liang Xia, Liang Xia, Hsing Jien Kung, Ai Hong Ma, Li Fen Lee, Philip E. Ryan, Characterization of a Novel Androgen Receptor Mutation in a Relapsed CWR22 Prostate Cancer Xenograft and Cell Line Cancer Research. ,vol. 62, pp. 6606- 6614 ,(2002)

F Berrino, M Gariboldi, C Melani, A Mogavero, T Negri, P Pasanisi, S Pilotti, M A Pierotti, Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene. ,vol. 32, pp. 1475- 1487 ,(2013) , 10.1038/ONC.2012.181

Thomas Fixemer, Ulrich Wissenbach, Veit Flockerzi, Helmut Bonkhoff, Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene. ,vol. 22, pp. 7858- 7861 ,(2003) , 10.1038/SJ.ONC.1206895

Xinnong Jiang, Sen Chen, John M. Asara, Steven P. Balk, Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic Subunits Journal of Biological Chemistry. ,vol. 285, pp. 14980- 14989 ,(2010) , 10.1074/JBC.M109.085696

Irina U. Agoulnik, Nancy L. Weigel, Androgen receptor action in hormone‐dependent and recurrent prostate cancer Journal of Cellular Biochemistry. ,vol. 99, pp. 362- 372 ,(2006) , 10.1002/JCB.20811